a:5:{s:8:"template";s:8632:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Lato:400,400italic,700,700italic|Lato:700|Lato:300|Lato:300&amp;subset=latin,latin-ext" id="x-font-custom-css" media="all" rel="stylesheet" type="text/css"/>
</head>
<style rel="stylesheet" type="text/css">.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}.has-drop-cap:not(:focus):after{content:"";display:table;clear:both;padding-top:14px}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}footer,header,nav{display:block}html{overflow-x:hidden;font-size:62.5%;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}a:focus{outline:thin dotted #333;outline:5px auto #ff2a13;outline-offset:-1px}a:active,a:hover{outline:0}.site:after,.site:before{display:table;content:""}.site:after{clear:both}body{margin:0;overflow-x:hidden;font-family:Lato,"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;font-size:1.4rem;font-weight:300;line-height:1.7;color:#7a7a7a;background:#f2f2f2}::-moz-selection{text-shadow:none;color:#7a7a7a;background-color:#eee}::selection{text-shadow:none;color:#7a7a7a;background-color:#eee}a{color:#ff2a13;text-decoration:none;-webkit-transition:color .3s ease,background-color .3s ease,border-color .3s ease,box-shadow .3s ease;transition:color .3s ease,background-color .3s ease,border-color .3s ease,box-shadow .3s ease}a:hover{color:#c61300}.x-container-fluid{margin:0 auto;position:relative}.x-container-fluid.max{max-width:1180px}.x-container-fluid.width{width:88%}ul{padding:0;margin:0 0 1.313em 1.655em}ul{list-style:disc}li{line-height:1.7}.collapse{display:none}.sf-menu li{position:relative}.sf-menu li:hover{visibility:inherit}.sf-menu a{position:relative}.x-navbar{position:relative;overflow:visible;border-bottom:1px solid #ccc;background-color:#fff;z-index:1030;font-size:14px;font-size:1.4rem;-webkit-box-shadow:0 .15em .35em 0 rgba(0,0,0,.135);box-shadow:0 .15em .35em 0 rgba(0,0,0,.135);-webkit-transform:translate3d(0,0,0);-ms-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}.x-nav-collapse.collapse{display:block;height:auto}.x-brand{display:inline-block;font-family:Lato,"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:54px;font-size:5.4rem;font-weight:700;letter-spacing:-3px;line-height:1;color:#272727}.x-brand:hover{text-decoration:none;color:#272727}.x-navbar .x-brand{float:left;display:block}.x-navbar .x-nav{margin:0}.x-navbar .x-nav>li{float:left}.masthead-inline .x-nav{display:block;float:right}.x-navbar .x-nav>li>a{float:none;padding:0 1.429em;line-height:1;font-weight:500;letter-spacing:2px;text-decoration:none;color:#b7b7b7}.x-navbar .x-nav li>a:after{content:"\f103";margin-left:.35em;letter-spacing:0;font-family:fontawesome!important;font-style:normal!important;font-weight:400!important;speak:none;-webkit-font-smoothing:antialiased}.x-navbar .x-nav li>a:only-child:after{content:"";display:none}.x-navbar .x-nav>li>a:hover{text-decoration:none;color:#272727;background-color:transparent;-webkit-box-shadow:inset 0 4px 0 0 #ff2a13;box-shadow:inset 0 4px 0 0 #ff2a13}.x-btn-navbar{display:none;padding:.458em .625em;font-size:24px;font-size:2.4rem;line-height:1;text-shadow:0 1px 1px rgba(255,255,255,.75);color:#919191;background-color:#f7f7f7;border-radius:4px;-webkit-box-shadow:inset 0 1px 4px rgba(0,0,0,.25);box-shadow:inset 0 1px 4px rgba(0,0,0,.25);-webkit-transition:box-shadow .3s ease,color .3s ease,background-color .3s ease;transition:box-shadow .3s ease,color .3s ease,background-color .3s ease}.x-btn-navbar:hover{color:#919191}.x-btn-navbar.collapsed{color:#b7b7b7;background-color:#fff;-webkit-box-shadow:inset 0 0 0 transparent,0 1px 5px rgba(0,0,0,.25);box-shadow:inset 0 0 0 transparent,0 1px 5px rgba(0,0,0,.25)}.x-btn-navbar.collapsed:hover{color:#919191;background-color:#f7f7f7;-webkit-box-shadow:inset 0 1px 4px rgba(0,0,0,.25);box-shadow:inset 0 1px 4px rgba(0,0,0,.25)}.x-navbar-fixed-top-active .x-navbar-wrap{margin-bottom:1px;height:90px}@media (max-width:979px){.x-navbar-fixed-top-active .x-navbar-wrap{margin-bottom:0;height:auto}}.x-nav{margin-left:0;margin-bottom:1.313em;list-style:none}.x-nav>li>a{display:block}.x-nav>li>a:hover{text-decoration:none;background-color:transparent}.x-colophon{position:relative;border-top:1px solid #d4d4d4;background-color:#fff;-webkit-box-shadow:0 -.125em .25em 0 rgba(0,0,0,.075);box-shadow:0 -.125em .25em 0 rgba(0,0,0,.075)}.x-colophon.bottom{padding:10px 0;font-size:10px;font-size:1rem;text-align:center;color:#7a7a7a}@media (max-width:979px){body.x-navbar-fixed-top-active{padding:0}.x-nav-collapse{clear:both;overflow:hidden}.x-nav-collapse.collapse{display:none}.x-nav-collapse .x-nav{float:none;margin:1.5em 0}.x-nav-collapse .x-nav>li{float:none}.x-navbar .x-nav-collapse .x-nav li a{display:block;height:auto;margin:2px 0;padding:.75em 1em;font-size:12px;font-size:1.2rem;line-height:1.5;white-space:normal;color:#b7b7b7;background-color:transparent;border-radius:4px;-webkit-transition:none;transition:none}.x-navbar .x-nav-collapse .x-nav li a:hover{color:#272727;background-color:#f5f5f5;-webkit-box-shadow:none;box-shadow:none}.masthead-inline .x-btn-navbar{display:block;float:right}}@media (min-width:980px){.x-nav-collapse.collapse{height:auto!important;overflow:visible!important}}@media print{*{background:0 0!important;color:#000!important;box-shadow:none!important;text-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}@page{margin:.5cm}}.visually-hidden{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}[class^=x-icon-]{display:inline-block;font-family:fontawesome;font-style:normal;font-weight:400;text-decoration:inherit;-webkit-font-smoothing:antialiased;speak:none}[class^=x-icon-]:before{speak:none;line-height:1}a [class^=x-icon-]{display:inline-block}.x-icon-bars:before{content:"\f0c9"} @font-face{font-family:Lato;font-style:italic;font-weight:700;src:local('Lato Bold Italic'),local('Lato-BoldItalic'),url(http://fonts.gstatic.com/s/lato/v16/S6u_w4BMUTPHjxsI5wq_FQfo.ttf) format('truetype')}@font-face{font-family:Lato;font-style:normal;font-weight:300;src:local('Lato Light'),local('Lato-Light'),url(http://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh7USSwaPHA.ttf) format('truetype')}@font-face{font-family:Lato;font-style:normal;font-weight:400;src:local('Lato Regular'),local('Lato-Regular'),url(http://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjxAwWw.ttf) format('truetype')}@font-face{font-family:Lato;font-style:normal;font-weight:700;src:local('Lato Bold'),local('Lato-Bold'),url(http://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwaPHA.ttf) format('truetype')}.visually-hidden{overflow:hidden;position:absolute;width:1px;height:1px;margin:-1px;border:0;padding:0;clip:rect(0 0 0 0)}</style>
<body class="x-integrity x-integrity-light x-navbar-fixed-top-active x-full-width-layout-active x-content-sidebar-active wpb-js-composer js-comp-ver-4.1.3 vc_responsive x-v2_6_0 x-shortcodes-v3_0_5">
<div class="site" id="top"> 
<header class="masthead masthead-inline" role="banner">
<div class="x-navbar-wrap">
<div class="x-navbar">
<div class="x-navbar-inner">
<div class="x-container-fluid max width">
<a class="x-brand img" href="#" title="{{ keyword }}">
{{ keyword }}
</a>
<a class="x-btn-navbar collapsed" data-target=".x-nav-collapse" data-toggle="collapse" href="#">
<i class="x-icon-bars"></i><span class="visually-hidden">Navigation</span>
</a>
<nav class="x-nav-collapse collapse" role="navigation">
<ul class="x-nav sf-menu" id="menu-main-nav"><li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-6780" id="menu-item-6780"><a href="#">Services</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-6676" id="menu-item-6676"><a href="#">Case</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-6779" id="menu-item-6779"><a href="#">Leadership</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-6673" id="menu-item-6673"><a href="#">Contact</a></li>
</ul>
</nav>  </div>
</div> 
</div> 
</div> 
</header>
{{ text }}
<footer class="x-colophon bottom" role="contentinfo">
<div class="x-container-fluid max width">
{{ links }}
</div>
{{ keyword }} 2021
</footer>
</div> 
</body>
</html>";s:4:"text";s:8264:"I spoke to my doctor yesterday she said if you have homozygous (two genes of the factor V Leiden) that you stay on it throughout and then they induce you because they need to control when you stop the injections for delivery then you continue it again 6 weeks postpartum. Genotypes distribution of Factor V Leiden 1691G/A and prothrombin gene 20210G/A in controls was in accordance with the Hardy–Weinberg equilibrium (P > 0.05). Women with recurrent pregnancy loss are offered Factor V Leiden (F5) and/or prothrombin G20210A (F2) testing to identify candidates for anticoagulation to improve outcomes. Factor V Leiden. The risk is increased 20- to 40-fold in women with homozygous Factor V Leiden. People with the factor V Leiden gene do not require treatment unless they have a clot. 6) Prothrombin G20210A variation. pulmonary embolism … It is fairly well known that the chemical changes caused by pregnancy create an increased risk for the development of dangerous blood clots. Factor V Leiden Symptoms. Factor V Leiden increases the risk of developing a DVT during pregnancy by about 7-fold. Subject: Re:Is Leiden factor V clotting mutation considered “qualifying” condition for COVID vaccine? Factor V Leiden and prothrombin 20210 G-A mutations are independent risk factors for venous thrombosis. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Factor V Leiden is caused by a genetic DNA mutation that increases the chance of blood clots. Pulmonary Embolism. The condition results in a factor V variant that cannot be as easily degraded by activated protein C. The gene that codes the protein is referred to as F5. Clots in the extremities can cause superficial thrombophlebitis or deep vein thrombosis (DVT), both painful conditions. After my twin pregnancy, I developed a near deadly clot. The patient is healthy, has no chronic medical conditions,and takes no long-term medications. Most women with factor V Leiden have normal pregnancies and only require close follow-up during pregnancy. People with the factor V Leiden gene do not require treatment unless they have a clot. Blood clots can be very serious and need to be treated quickly. Factor V Leiden carriage has consistently been shown to increase the risk of early onset gestational hypertension and HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) in pregnancy. Thrombophilia caused by Factor V Leiden The abnormality of Factor 5 clotting protein usually called Factor V Leiden is the commonest inherited problem associated with an increased risk of thrombosis. Management Factor V Leiden (FVL) mutation . Factor V Leiden is an inherited disorder and can therefore be passed on to your children. In FVL, factor V remains active, which allows over production of thrombin, leading to excess clotting. described in Leiden, Netherlands • Heterozygous = 1 gene (passed down from mom or dad) = common • About 5 in 100 (1 in 20) people have this • Homozygous = 2 genes (from mom and dad) = rare • Information on this sheet focuses on people who have heterozygous Factor V Leiden • This is weak risk factor for clot. To address this limitation, here we implemented first meta-analysis to provide with consistent … Thrombophilia might increase the risk of RPL by adversely affecting the normal placental vascular function. Retrospective studies variably suggest a link between maternal FVL/PGM and placenta-mediated pregnancy complications including pregnancy loss, small for gestational age, pre-eclampsia and placental abruption. Most women with factor V Leiden have normal pregnancies and only require close follow-up during pregnancy. The association of factor V Leiden mutation with recurrent pregnancy loss. Material and methods: In a prospective study of 2480 unselected … Our objective was to undertake a systematic review and a metaanalysis of the literature to estimate precisely the association of factorV Leiden mutation with the risk of first, or recurrent, pregnancy-related venous thromboembolism. Keywords:factor v leiden, thrombophilia, thrombosis, pregnancy outcome, pregnancy loss Abstract: There is growing evidence that women with thrombophilia are at increased risk of pregnancy related venous thromboembolism and of adverse pregnancy outcome including pregnancy loss, pre-eclampsia, intrauterine growth retardation and placental abruption. Factor V Leiden is a variant of the protein Factor V (5), which is needed for blood clotting. The Leiden mutation has been significantly related to pregnancy complications associated with hypercoagulation, e.g. For reasons of comparison, we included women who were factor V Leiden heterozygous and a group of noncarriers. The factor V Leiden mutation is the most common genetic risk factor for deep vein thrombosis: it is present in about 5% of the white population. Factor V Leiden > Factor V Leiden occurs as a result of a single point mutation in the factor V gene at the cleavage site (position 506) where protein C acts. Thrombophilia increases your risk of: deep vein thrombosis (DVT), a blood clot in a vein, usually the leg. Factor V Leiden (FVL) is a change in your genes that affects one of the clotting factors in your blood and keeps your … Factor V Leiden thrombophilia is a genetic disorder that makes it more likely for you to develop a blood clot sometime during your life.Still, it is estimated that 95% of people with factor V Leiden never develop a clot. The impact of the factor V Leiden mutation on pregnancy A resistance to the anticoagulant activity of activated protein C (APC), most frequently due to a point mutation in the Factor V gene (the Leiden mutation), represents the most common genetic cause of thrombophilia. Low Birth Weight. Factor V Leiden mutation is the most common inherited thrombophilia, occurring in approximately 5% of the White and 1% of the Black populations. It’s most commonly found in Caucasians (3-8%). Second, we looked for an interaction between these 2 mutations in patients with recurrent fetal loss or thrombosis in pregnancy. There have been dozens of studies that have attempted to answer this question. Having 1 Factor V Leiden gene (heterozygous type) slightly increases the chance of developing a blood clot. Although heterozygosity for the factor V Leiden mutation is a risk factor for the development of an initial episode of venous thrombosis, the risk for recurrent venous thrombosis in such a patient is not greater than that in those without an underlying thrombophilic abnormality. Although it increases your risk of having a blood clot, the vast majority of people with this condition never have a clot. When a parent is heterozygous for Factor V Leiden, each child has a 50% We studied the frequency of these mutations in 35 patients who had thromboembolic events during pregnancy and puerperium, and in 32 women who had a history of uncomplicated pregnancy, delivered either vaginally or by cesarean section, and did not have a past history of … Factor V (pronounced factor five) is a protein of the coagulation system, rarely referred to as proaccelerin or labile factor.In contrast to most other coagulation factors, it is not enzymatically active but functions as a cofactor.Deficiency leads to predisposition for hemorrhage, while some mutations (most notably factor V Leiden) predispose for thrombosis The mutation for FV Leiden is inherited in an autosomal dominant fashion and, therefore, may also be potentially inherited from the father. Inheriting one copy (Factor V Leiden Heterozygous) of the mutation from a parent increases by fourfold to eightfold the chance of developing a clot. When combined with the hypercoagulable state that is characteristic of pregnancy, there is an increased risk of severe and recurrent pregnancy complications. Other factors also increase the risk of developing blood clots in people with factor V Leiden thrombophilia. Pregnancy. Conclusion: This study indicates that screening for factor V Leiden mutation and prothrombin gene mutation in pregnancy might not be of any clinical significance among Nigerian women. We compared pregnancy outcomes of 11 women with a heterozygous form of the factor V Leiden mutation with 41 women of a control group. ";s:7:"keyword";s:25:"factor v leiden pregnancy";s:5:"links";s:1110:"<a href="http://truck-doctor.com/e2qbi/carmax-commercial-girl-in-hoodie">Carmax Commercial Girl In Hoodie</a>,
<a href="http://truck-doctor.com/e2qbi/build-process-heap-size-intellij">Build Process Heap Size Intellij</a>,
<a href="http://truck-doctor.com/e2qbi/full-grill-design-for-veranda">Full Grill Design For Veranda</a>,
<a href="http://truck-doctor.com/e2qbi/craigslist-pine-level%2C-nc">Craigslist Pine Level, Nc</a>,
<a href="http://truck-doctor.com/e2qbi/sustainable-sweatshirt">Sustainable Sweatshirt</a>,
<a href="http://truck-doctor.com/e2qbi/fashion-hoodies-women%27s">Fashion Hoodies Women's</a>,
<a href="http://truck-doctor.com/e2qbi/how-to-make-biodegradable-water-bottles">How To Make Biodegradable Water Bottles</a>,
<a href="http://truck-doctor.com/e2qbi/beef-gravy-without-drippings-food-network">Beef Gravy Without Drippings Food Network</a>,
<a href="http://truck-doctor.com/e2qbi/who-said-a-house-divided-cannot-stand">Who Said A House Divided Cannot Stand</a>,
<a href="http://truck-doctor.com/e2qbi/catholic-charities-food-pantry-near-me">Catholic Charities Food Pantry Near Me</a>,
";s:7:"expired";i:-1;}